The Authors Respond

J Manag Care Spec Pharm. 2020 Apr;26(4):569-570. doi: 10.18553/jmcp.2020.26.4.569.

Abstract

The writing of the original report referred to in this letter was sponsored by the Institute for Clinical and Economic Review (ICER). Agboola, Fazioli, and Pearson are employed by ICER. Touchette reports grants from ICER during the course of the original work and personal fees from Monument Analytics, unrelated to this work. Atlas has nothing to disclose.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antidepressive Agents* / economics
  • Antidepressive Agents* / therapeutic use
  • Cost-Benefit Analysis
  • Humans

Substances

  • Antidepressive Agents